Objectives COVID-19 patients suffer from the lack of curative therapy. Hence, there is an
urgent need to try repurposed old drugs on COVID-19. Methods Randomized controlled study …

about 4 days and showed less death rate [1/21 versus 8/28 in control group]. In addition, all
the patients who were given convalescent plasma showed high levels of SARS-CoV-2 IgG …

Objectives The current COVID-19 pandemic needs unconventional therapies to tackle the
resulted high morbidity and mortality. Convalescent plasma is one of the therapeutic …

Coronavirus disease 2019 (COVID-19) is a recent respiratory infection caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with serious complications, …

COVID-19 patients suffer from the lack of curative therapy. Hence, there is an urgent need to
try repurposed old drugs on COVID-19. Randomized controlled study on 70 COVID-19 …

The novel coronavirus that causes the now well-known COVID-19 illness has affected the
whole world as the number of daily reported cases has exceeded 250,000. The spread trend …

COVID-19, which stands for Coronavirus disease 2019, is an infection caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first reported in December 2019 in …

… Pseudovirus capture assay, VN k assay using SARS-CoV-2 strains and Vero-E6 cells In
vitro … After 48 h of infusion, no detectable virus in qPCR k from nasopharyngeal exudate Not …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed
our lives. The scientific community has been investigating re-purposed treatments to prevent …

Purpose of the study Currently no treatment has been proven to be efficacious for patients
with early symptoms of COVID-19. Although most patients present mild or moderate symptoms…